Jefferson Health

Physician Profile

Hie-Won Hann, MD, FAASLD

Jefferson University Physician

Academic Title: Professor
Director, Liver Disease Prevention Center at Division of Gastroenterology and Hepatology

Specialties
Gastroenterology - Hepatology
Gastroenterology - Liver Disease/Cancer
Gastroenterology (Not Accepting New Patients)

Make An Appointment

Click to call 1-800-JEFF-NOW (800-533-3669) or

Office Locations

Philadelphia
132 S. 10th Street
Suite 480
Philadelphia PA 19107
Phone: (215) 955-8900
Fax: (215) 503-2527

Medical Services

Years in Practice

45

Hospital Affiliation / Admitting Privileges

  • Thomas Jefferson University Hospital

Awards and Honors

Women in Leadership Award, Women's Way 1993

Fellow Koreans who made the Nation Proud Award, Korean Government 1995

Order of Civic Merit Award, Mokryon-Jang, President Kim Young Sam 1996

Distinguished Leadership Award, Hepatitis B Foundation 1999

Proud Medical Alumnus Award, Seoul National University 2001

Ham Choon Medical Science Award, Seoul National University College of 2001

A Distinguished Daughter of Pennsylvania 2003

Notes

Between 1971-1988, I have been a member (physician)of Clinical Research Divison and the Co-Director of Liver Cancer Prevention Center, Fox Chase Cancer Center under the Direction of Dr. Baruch S. Blumberg, the 1976 Nobel Laureate for Discovery of Hepatitis B Virus. My goal is to provide the best care for patients with chronic hepatitis B and liver cancer utilizing the most updated therapy for hepatitis B virus infection to prevent liver cancer.

Personal Statement

To provide the best care possible for each of my patients using current treatment methods. I tailor my care to patients on an individualized basis. One on one contact between the doctor and patient is imperative to a successful healing relationship. This includes discussion of multiple factors that affect the patient's health and educating the patient about the illness. Improving the quality of life is my primary goal.

Education

  • Seoul National University, Korea, Medical School

Internship

  • Seoul National University, Korea
  • Worcester City Hospital

Residency

  • Children's Hospital of Boston

Fellowship

  • Dana Farber Cancer Institute

Recent Publications

Circulating Mitochondrial DNA Content Associated with the Risk of Liver Cirrhosis: A Nested Case–Control Study

Aspartate aminotransferase to platelet ratio index as a prospective predictor of hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection

A long-term study of the effects of antiviral therapy on survival of patients with HBV-associated hepatocellular carcinoma (HCC) following local tumor ablation

Then and now: The progress in hepatitis B treatment over the past 20 years

Prevention of hepatocellular carcinoma and its recurrence with anti-hepatitis B viral therapy

HBV-related health behaviors in a socio-cultural context: Perspectives from Khmers and Koreans

Randomized comparison of Tenofovir disoproxil fumarate vs emtricitabine and tenofovir disoproxil fumarate in patients with lamivudine-resistant chronic hepatitis B

Single-center comparison of three chemoembolization regimens for hepatocellular carcinoma

Correlates of Hepatitis B Virus Health-Related Behaviors of Korean Americans: A Situation-Specific Nursing Theory

Comprehensive Analysis of Common Serum Liver Enzymes as Prospective Predictors of Hepatocellular Carcinoma in HBV Patients

Predictive value of alpha-fetoprotein in the long-term risk of developing hepatocellular carcinoma in patients with hepatitis B virus infection - Results from a clinic-based longitudinal cohort

Telomere length in circulating serum DNA as a novel non-invasive biomarker for cirrhosis: A nested case-control analysis

Erratum: Recognition and management of HBV infection in a social context (Journal of Cancer Education DOI: 10.1007/s13187-011-0203-5)

Relative telomere length: A novel non-invasive biomarker for the risk of non-cirrhotic hepatocellular carcinoma in patients with chronic hepatitis B infection

The management of chronic hepatitis B in Asian Americans

Recognition and management of HBV infection in a social context

Extended treatment with lamivudine and adefovir dipivoxil in chronic hepatitis B patients with lamivudine resistance

Prevention of new hepatocellular carcinoma with concomitant antiviral therapy in chronic hepatitis B patients whose initial tumor was successfully ablated

Analysis of GP73 in patients with HCC as a function of anti-cancer treatment

Telbivudine: An effective anti-HBV drug for chronic hepatitis B patients with early on-treatment responses